Cardiovascular systems, inc. (CSII)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11
ASSETS
Current assets
Cash and cash equivalents

69,572

65,467

58,939

74,237

115,280

118,772

113,370

116,260

109,305

107,345

104,747

107,912

103,130

79,279

58,194

60,638

62,174

65,329

76,651

83,842

93,485

101,344

116,423

126,592

145,979

146,664

63,227

67,897

69,932

29,223

32,213

35,529

22,455

24,558

22,676

21,159

Marketable Securities, Current

37,688

43,954

46,028

48,435

456

434

505

544

586

636

668

704

741

721

705

684

1,909

1,871

1,794

1,876

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accounts Receivable, after Allowance for Credit Loss, Current

30,864

35,833

34,624

36,015

34,970

29,906

30,320

31,225

31,941

27,861

27,316

28,472

27,877

25,398

24,308

23,128

23,048

25,752

26,864

30,830

31,220

26,064

22,376

21,383

19,493

15,918

15,271

14,730

15,187

13,020

13,467

13,644

12,990

12,460

11,762

13,254

Inventory, Net

24,069

21,472

19,489

18,058

19,304

19,679

18,095

16,605

17,002

17,401

17,035

16,897

16,605

16,169

16,887

17,440

18,226

18,237

15,446

13,966

13,219

13,957

14,644

12,890

11,889

10,283

8,266

6,243

6,796

7,161

6,962

7,061

7,824

7,963

7,055

5,818

Prepaid expenses and other current assets

2,243

2,961

2,858

3,330

2,221

1,944

2,248

2,977

2,350

2,556

6,031

5,074

3,479

1,382

1,998

2,992

1,388

1,577

2,603

3,380

3,904

4,084

3,587

1,846

1,018

1,476

1,231

959

778

1,124

1,249

1,536

980

1,413

1,212

797

Total current assets

164,436

169,687

161,938

180,075

172,231

170,735

164,538

167,611

161,184

155,799

155,797

159,059

151,832

122,949

102,092

104,882

106,745

112,766

123,358

133,894

141,828

145,449

157,030

162,711

178,379

174,341

87,995

89,829

92,693

50,528

53,891

57,770

44,249

46,394

42,705

41,028

Property and equipment, net

27,692

27,320

27,367

27,324

27,607

28,230

27,388

27,744

28,165

28,729

29,164

29,696

30,213

31,204

31,820

32,471

33,224

33,564

33,711

32,883

32,359

30,940

21,238

15,297

3,420

3,088

3,022

2,999

2,532

2,342

2,122

2,163

2,257

2,388

2,271

2,383

Intangible assets, net

20,256

20,571

20,991

5,105

5,242

5,307

5,501

5,231

5,148

5,386

5,278

5,056

4,752

4,503

4,352

5,013

4,952

4,759

4,787

4,511

4,399

4,150

4,015

3,823

3,620

3,505

3,418

3,219

3,066

2,938

2,903

2,635

2,659

2,499

2,422

2,314

Other assets

7,694

6,614

6,769

6,073

6,149

2,915

2,883

2,766

262

150

118

129

60

64

70

40

88

136

534

40

40

70

70

70

-

-

-

-

-

-

-

-

-

-

-

-

Debt conversion option and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

70

70

685

850

742

839

1,170

556

656

726

906

1,033

Total assets

220,078

224,192

217,065

218,577

211,229

207,187

200,310

203,352

194,759

190,064

190,357

193,940

186,857

158,720

138,334

142,406

145,009

151,225

162,390

171,328

178,626

180,609

182,353

181,901

185,489

181,004

95,120

96,897

99,033

56,647

60,086

63,124

49,821

52,007

48,304

46,758

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Current maturities of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,200

2,400

3,600

5,050

5,074

5,095

4,928

4,678

4,678

4,678

3,478

2,337

3,905

3,813

Accounts payable

13,235

16,560

13,106

11,194

12,396

12,998

13,005

10,441

9,836

9,716

10,674

10,736

8,813

7,616

8,763

8,506

8,338

8,313

9,815

9,763

17,527

18,302

18,196

9,703

11,329

8,511

8,520

7,230

6,183

5,012

5,595

5,610

5,072

5,633

5,203

5,181

Deferred grant incentive

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

127

151

151

-

176

302

322

302

784

995

647

647

Accrued expenses

35,064

35,074

32,085

29,387

26,489

24,472

22,008

25,776

24,765

22,680

25,584

30,236

29,837

24,762

21,688

26,993

26,649

19,651

20,047

20,125

16,356

12,185

12,619

17,626

14,009

11,092

10,209

10,088

8,668

6,946

8,692

7,262

6,804

5,300

5,340

5,545

Deferred revenue current

1,757

1,656

1,706

1,764

1,612

1,519

1,248

1,243

1,554

1,095

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

50,056

53,290

46,897

42,345

40,497

38,989

36,261

37,460

36,155

33,491

36,258

40,972

38,650

32,378

30,451

35,499

34,987

27,964

29,862

29,888

33,883

30,487

32,015

29,729

29,065

24,804

23,954

22,413

19,955

16,938

19,287

17,852

16,138

14,265

15,095

15,186

Long-term liabilities
Financing obligation

20,868

20,903

20,938

20,972

21,005

21,025

21,045

21,064

21,083

21,088

21,094

21,100

20,973

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue noncurrent

5,258

5,740

6,076

6,541

7,230

7,700

8,122

8,946

9,023

8,905

10,000

10,000

10,000

10,000

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Long-term debt, net of current maturities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

5,742

7,472

8,851

10,400

11,621

12,842

14,063

15,403

8,443

8,331

Deferred grant incentive

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

199

336

1,315

-

Other liabilities

720

954

1,080

775

884

875

903

1,412

2,042

2,620

2,902

3,479

3,752

4,266

4,939

6,010

8,251

1,986

1,916

2,005

2,004

1,967

1,891

117

112

123

153

180

242

151

192

241

82

103

106

1,606

Total long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

112

123

5,895

7,652

9,093

10,551

11,813

13,083

14,344

15,842

9,864

9,937

Total liabilities

76,902

80,887

74,991

70,633

69,616

68,589

66,331

68,882

68,303

66,104

70,254

75,551

73,375

46,644

35,390

41,509

43,238

29,950

31,778

31,893

35,887

32,454

33,906

29,846

29,177

24,927

29,849

30,065

29,048

27,489

31,100

30,935

30,482

30,107

24,959

25,123

Commitments and contingencies (see Note 10)

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Common stock, $0.001 par value; authorized 100,000,000 common shares; issued and outstanding 35,274,479 at March 31, 2020 and 34,934,569 at June 30, 2019, respectively

34

34

34

34

34

34

33

33

33

33

33

33

33

33

33

33

33

33

32

32

32

32

31

31

31

30

25

24

24

21

21

20

18

18

18

17

Additional paid in capital

491,053

487,780

482,760

477,368

472,501

469,827

465,382

461,927

457,648

455,508

451,246

447,559

443,427

440,292

432,119

428,235

424,178

421,005

415,236

410,700

405,320

400,185

395,205

390,589

385,218

371,703

269,725

261,722

257,474

210,119

203,799

201,793

184,464

182,835

180,487

174,157

Accumulated other comprehensive (loss) income

-59

93

102

78

0

0

0

101

103

112

104

100

97

77

61

40

86

48

-9

90

105

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Common stock warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

3,569

6,088

8,361

8,921

9,233

9,614

9,614

9,489

9,489

9,147

9,909

Accumulated deficit

-347,852

-344,602

-340,822

-329,536

-330,922

-331,263

-331,436

-327,591

-331,328

-331,693

-331,280

-329,303

-330,075

-328,326

-329,269

-327,411

-322,526

-299,811

-284,647

-271,387

-262,718

-252,062

-246,789

-238,565

-228,937

-219,225

-210,567

-203,275

-196,434

-190,215

-184,448

-179,238

-174,632

-170,442

-166,307

-162,448

Total stockholders’ equity

143,176

143,305

142,074

147,944

141,613

138,598

133,979

134,470

126,456

123,960

120,103

118,389

113,482

112,076

102,944

100,897

101,771

121,275

130,612

139,435

142,739

148,155

148,447

152,055

156,312

156,077

65,271

66,832

69,985

29,158

28,986

32,189

19,339

21,900

23,345

21,635

Total liabilities and stockholders’ equity

220,078

224,192

217,065

218,577

211,229

207,187

200,310

203,352

194,759

190,064

190,357

193,940

186,857

158,720

138,334

142,406

145,009

151,225

162,390

171,328

178,626

180,609

182,353

181,901

185,489

181,004

95,120

96,897

99,033

56,647

60,086

63,124

49,821

52,007

48,304

46,758